abrdn Healthcare Investors
123 hedge funds and large institutions have $248M invested in abrdn Healthcare Investors in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 12 closing their positions.
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
20% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 30
11% more capital invested
Capital invested by funds: $223M → $248M (+$25M)
3% more funds holding
Funds holding: 120 → 123 (+3)
1.86% more ownership
Funds ownership: 22.41% → 24.27% (+1.9%)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$9.09M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.77M |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
+$2.31M |
| 4 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$1.9M |
| 5 |
LPL Financial
San Diego,
California
|
+$1.81M |
Top Sellers
HQH Hedge Fund Activity: Q4 2025 in Review
123 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in abrdn Healthcare Investors (HQH) for Q4 2025, worth a combined $248M — up 11% from $223M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new HQH positions and 12 closed out — a net gain of 8 holders — while 36 added to existing stakes and 30 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $9.09M. The largest seller was Thomas J. Herzfeld Advisors, exiting entirely with an estimated $1.75M sold.
- 123 institutional investors held abrdn Healthcare Investors (HQH) as of Q4 2025, up from 120 in Q3 2025.
- Funds reported $248M of abrdn Healthcare Investors stock for Q4 2025, up 11% quarter-over-quarter.
- 20 funds opened new abrdn Healthcare Investors positions in Q4 2025 and 12 closed out, a net change of +8 holders.
- The largest abrdn Healthcare Investors buyer in Q4 2025 was Morgan Stanley, an estimated $9.09M added.
- The largest abrdn Healthcare Investors seller in Q4 2025 was Thomas J. Herzfeld Advisors, an estimated $1.75M sold.
Based on aggregated 13F filings for Q4 2025.